Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Carlos R. Diaz"'
Autor:
Kassandra Bosire, Patricia D. Jones, Olveen Carrasquillo, Paul J. Martin, Harry Nguyen, Shweta Anjan, Carlos R. Diaz, Jonathan Tu, Stefanie Brown, Mahmoud Mahfouz
Publikováno v:
Digestive Diseases and Sciences. 65:2551-2561
Hepatitis B (HBV), the leading cause of hepatocellular carcinoma (HCC) worldwide, disproportionately affects minorities in the USA. Undiagnosed HBV precludes HCC screening and contributes to late-stage cancer presentation and decreased survival. Barr
Autor:
Mahmoud, Mahfouz, Harry, Nguyen, Jonathan, Tu, Carlos R, Diaz, Shweta, Anjan, Stefanie, Brown, Kassandra, Bosire, Olveen, Carrasquillo, Paul, Martin, Patricia D, Jones
Publikováno v:
Digestive diseases and sciences. 65(9)
Hepatitis B (HBV), the leading cause of hepatocellular carcinoma (HCC) worldwide, disproportionately affects minorities in the USA. Undiagnosed HBV precludes HCC screening and contributes to late-stage cancer presentation and decreased survival. Barr
Autor:
Shweta Anjan, Mahmoud Mahfouz, Harry Nguyen, Olveen Carrasquillo, Carlos R. Diaz, Stefanie Brown, Kassandra Bosire, Jonathan Tu, Paul M. Martin, Patricia D. Jones
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 29:B002-B002
Background: Hepatitis B (HBV), a leading cause of hepatocellular carcinoma (HCC) worldwide, disproportionately affects minorities in the United States. Undiagnosed HBV infection precludes HCC screening and contributes to late-stage presentation and d
Publikováno v:
Gastroenterology. 158:S-290
Autor:
Jessica Zuleta, Tara Keihanian, Carlos R. Diaz, Reginald Pereira, Juan E. Corral, Ryan M. Dauer
Publikováno v:
American Journal of Gastroenterology. 111:S842-S843
Autor:
Patricia D. Jones, Beatrice L. Madrazo, Gennaro Selvaggi, Debra Payne, Carlos R. Diaz, Paul L. Martin
Publikováno v:
Gastroenterology. 154:S-1237
Publikováno v:
Journal of gastrointestinal cancer. 46(3)
Publikováno v:
Gastrointestinal Endoscopy. 83:AB514-AB515
Publikováno v:
Antimicrobial Agents and Chemotherapy. 12:98-101
Nafcillin, a pencillinase-resistant penicillin, is frequently used for treatment of staphylococcal infections in hemodialysis patients. Despite its widespread use, there is a paucity of available data regarding the pharmacokinetics of nafcillin in he
Publikováno v:
Antimicrobial Agents and Chemotherapy. 11:965-967
The entry of nafcillin into the cerebrospinal fluid (CSF) of humans was studied in the absence of meningeal inflammation. Twenty studies were performed in 18 patients receiving 40 mg of sodium nafcillin per kg intravenously over 30 min. The CSF speci